Network analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease.
Increasing evidence indicates that Parkinson's disease (PD) and type 2 diabetes (T2DM) share dysregulated molecular networks. We identified 84 genes shared between PD and T2DM from curated disease-gene databases. Nitric oxide biosynthesis, lipid and carbohydrate metabolism, insulin secretion an...
Main Authors: | Jose A Santiago, Clemens R Scherzer, Judith A Potashkin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4184821?pdf=render |
Similar Items
-
Evaluation of RNA Blood Biomarkers in the Parkinson’s Disease Biomarkers Program
by: Jose A. Santiago, et al.
Published: (2018-05-01) -
Regulatory miRNA–mRNA Networks in Parkinson’s Disease
by: Bruno Lopes Santos-Lobato, et al.
Published: (2021-06-01) -
Exploring MicroRNA Biomarkers for Parkinson’s Disease from mRNA Expression Profiles
by: Y-h. Taguchi, et al.
Published: (2018-12-01) -
Integrated analysis of circRNA-miRNA-mRNA regulatory network identifies potential diagnostic biomarkers in diabetic foot ulcer
by: Shuping Liao, et al.
Published: (2020-09-01) -
Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients.
by: Jose A Santiago, et al.
Published: (2015-01-01)